[Various new pathogens in pneumonia].

C Regamey

Home/Archive/PubMed

PubMed · 8525335

[Various new pathogens in pneumonia].

C Regamey

View original source ↗Export metadata ↓

Abstract

The table summarizes the many newly recognized agents causing lower respiratory tract infections: gram + cocci, Streptococcus agalactiae, enterococci; gram-rods, acinetobacter, Aeromonas hydrophila, Eikenella corrodens; Mycobacterium tuberculosis resistant to multiple drugs, intracellular organisms and viruses. Some details are given in four chapters: Pneumococci resistant to penicillin G which must be detected and impose new therapeutic strategies; Chlamydia pneumoniae with its difficulties for the diagnosis and the absence of standardized therapeutic trials; Streptococcus pyogenes with a recrudescence of severe and invasive infections, TSS and virulence factors; the pulmonary Hantavirus syndrome with 105 patients recognized (mortality 52%) in the USA and Canada, the homeland of the deermouse (Peromiscus maniculatus).

Explore related subjects

Chlamydophila pneumoniae Orthohantavirus Humans Penicillin G Penicillin Resistance Pneumonia, Bacterial Pneumonia, Viral Streptococcus pneumoniae Streptococcus pyogenes Virulence English Abstract Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

C Regamey. 1995-11-11. [Various new pathogens in pneumonia].. https://pubmed.ncbi.nlm.nih.gov/8525335/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens.

The objectives of this study were to evaluate the performance of the NucliSens easyMAG platform for nucleic acid extraction from different clinical specimens compared to NucliSens miniMAG platform and manual QIAGEN extraction. The NucliSens easyMAG and the NucliSens miniMAG showed equal performance on 215 throat swabs since real-time nucleic acid sequence-based amplification scored the same samples positive for Mycoplasma pneumoniae (n=9) and Chlamydia pneumoniae (n=5) RNAs, although internal control RNA was slightly better detected with the NucliSens easyMAG (99.3% versus 96.8%). NucliSens easyMAG extracted nucleic acids more efficiently (higher recovery and/or fewer inhibitors) compared to QIAGEN extraction by showing, on average, lower Ct values in real-time LightCycler PCR, although 4 individual specimen out of 45 were found positive only with QIAGEN. For nine M. pneumoniae-positive throat swabs, the mean difference in Ct values between NucliSens easyMAG extraction and QIAGEN extraction was -2.26 (range, -5.77 to +0.60); for the detection of five C. pneumoniae-positive throat swabs, the average difference in Ct values between the two methods was -3.38 (range, -6.62 to -2.02); and for the detection of cytomegalovirus in 24 blood samples, the mean difference in Ct values between the two methods was -0.95 (range, -5.51 to +1.68). The NucliSens easyMAG is considerably easier to perform, efficiently extracts nucleic acids from throat swabs and whole blood, is automated, and has high throughput.

Chlamydophila pneumoniae↗

PubMed2006

Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.

Isothermal nucleic acid sequence-based amplification (NASBA) was applied to the detection of Chlamydophila pneumoniae 16S rRNA by using the NucliSens basic kit (bioMérieux, Boxtel, The Netherlands). The assay was originally developed as a conventional NASBA assay with electrochemiluminescence detection and was subsequently adapted to a real-time NASBA format by using a molecular beacon. C. pneumoniae RNA prepared from a plasmid construct was used to assess the analytical sensitivity of the assay. The sensitivity of the NASBA assay was 10 molecules of in vitro wild-type C. pneumoniae RNA and 0.1 inclusion-forming unit (IFU) of C. pneumoniae. In spiked respiratory specimens, the sensitivity of the C. pneumoniae NASBA assay varied between 0.1 and 1 IFU/100 mul sample, depending on the type of specimen. Finally, conventional and real-time NASBA were applied to respiratory specimens previously tested by PCR. A 100% concordance between the test results was obtained.

Chlamydophila pneumoniae↗

PubMed2005

Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells.

Nicotine, the addictive component of cigarette smoke, has been shown to have immunomodulatory effects. This drug alters proinflammatory cytokine production by immune cells, including lymphocytes, monocytes, and macrophages. The present study focuses on the effects of nicotine on infection by Chlamydia pneumoniae (Cpn), a ubiquitous intracellular pathogen which causes acute and chronic inflammatory diseases such as pulmonary infections, and may be associated with arthritis and atherosclerosis. Previous studies in our laboratory showed that lymphocytes and macrophages are susceptible to Cpn infection. The present study aimed at investigating the effect of nicotine on TGF-beta1, IL-10, IL-12, and TNF-alpha production in Cpn-infected human peripheral blood mononuclear cells (PBMCs). Cytokine levels in the supernatant were assessed by ELISA. The results showed that Cpn infection alters the expression levels of IL-10, IL-12, and TNF-alpha in a time-dependent fashion. Nicotine treatment of the Cpn-infected cells up-regulated IL-10, but not TNF-alpha and IL-12, and also resulted in significant down-regulation of TGF-beta1 production which was marked in the Cpn-infected control cells. The combined action of nicotine and Cpn on cytokine production may have an impact in chronic inflammatory diseases.

Chlamydophila pneumoniae↗